Richard Pilnik
Board Member
DiaMedica Therapeutics Inc. (DMAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Pilnik
Richard Pilnik is recorded as Board Member at DiaMedica Therapeutics Inc. (DMAC). DiaMedica Therapeutics Inc. reported in an 8-K filed March 6, 2025 that Richard Pilnik retired as member of the Board of Directors, effective May 15, 2025. DiaMedica Therapeutics Inc. reported in an 8-K filed May 23, 2024 that Richard Pilnik was appointed Director, effective May 22, 2024.
“On February 28, 2025, Richard Pilnik, who has been a member of the Board of Directors (the "Board") of DiaMedica Therapeutics Inc. (the "Company"), for over 15 years, informed the Company of his decision to retire and not to stand for re-election at the Company's 2025 Annual General Meeting of Shareholders (the "AGM").”
“The seven director nominees proposed by the Board were elected to serve as members of the Board until the next annual general meeting of shareholders and until their respective successors are duly elected and qualified by the following final voting results”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-22–present
-
2024-05-22–2025-05-15
-
Start not stated–2024-04-04
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at DiaMedica Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Rick Pauls CEO, Board Member
- James Parsons Chairman
- Charles Semba Board Member
- Charles Semba, M.D. Board Member
- Daniel J. O'Connor Board Member
- Daniel O’Connor Board Member
- Michael Giuffre Board Member
- Michael Giuffre, M.D. Board Member
- Richard E. Kuntz, M.D., M.Sc. Board Member
- Richard Kuntz Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.